HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Friedrich Overkamp Selected Research

Diarrhea

1/2020Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Friedrich Overkamp Research Topics

Disease

31Breast Neoplasms (Breast Cancer)
04/2021 - 01/2008
10Neoplasms (Cancer)
02/2021 - 04/2012
4Triple Negative Breast Neoplasms
04/2021 - 10/2019
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2012
3Neoplasm Metastasis (Metastasis)
01/2020 - 04/2012
2Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 03/2018
2Vomiting
03/2018 - 12/2017
2Nausea
03/2018 - 12/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2020
1Injection Site Reaction
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Diarrhea
01/2020
1Intestinal Perforation
01/2020
1Peritonitis
01/2020
1Tinnitus
01/2020
1Brain Neoplasms (Brain Tumor)
12/2018
1Disease Progression
10/2018
1Alopecia (Baldness)
03/2018
1Renal Cell Carcinoma (Grawitz Tumor)
01/2013
1Multiple Myeloma
04/2009

Drug/Important Bio-Agent (IBA)

9Hormones (Hormone)IBA
04/2021 - 01/2011
4pertuzumabIBA
11/2020 - 01/2019
4Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2020 - 03/2018
3Biomarkers (Surrogate Marker)IBA
11/2020 - 03/2018
2Pharmaceutical PreparationsIBA
02/2021 - 12/2020
2Ado-Trastuzumab EmtansineIBA
10/2020 - 10/2019
2L-BLP25IBA
01/2020 - 04/2012
2Trastuzumab (Herceptin)FDA Link
01/2019 - 12/2017
2Tyrosine Kinase InhibitorsIBA
12/2017 - 01/2013
1AlpelisibIBA
04/2021
1sacituzumab govitecanIBA
04/2021
1Phenobarbital (Luminal)FDA Link
04/2021
1Immunoconjugates (Immunoconjugate)IBA
04/2021
1larotrectinibIBA
02/2021
1entrectinibIBA
02/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1histidine-rich proteinsIBA
11/2020
1seribantumabIBA
11/2020
1Immune Checkpoint InhibitorsIBA
04/2020
1Saline SolutionIBA
01/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
1LipidsIBA
01/2020
1Mucin-1 (CA 15-3 Antigen)IBA
01/2020
1atezolizumabIBA
12/2019
1Biological ProductsIBA
10/2019
1Bevacizumab (Avastin)FDA Link
01/2019
1Carbonic Anhydrase IXIBA
01/2019
1human ERBB2 proteinIBA
12/2018
1PhosphoproteinsIBA
10/2018
1neratinibIBA
12/2017
1Sorafenib (BAY 43-9006)FDA Link
07/2017
1Paclitaxel (Taxol)FDA LinkGeneric
07/2017
1N,N'-bis(4-azidobenzoyl)cystineIBA
02/2016
1taxaneIBA
01/2013
1EverolimusFDA Link
01/2013
1AnthracyclinesIBA
01/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1Glycoproteins (Glycoprotein)IBA
04/2012
1Fulvestrant (Faslodex)FDA Link
01/2011
1Bortezomib (Velcade)FDA Link
04/2009

Therapy/Procedure

31Therapeutics
04/2021 - 01/2008
4Drug Therapy (Chemotherapy)
10/2019 - 12/2017
3Immunotherapy
12/2019 - 04/2012
2Neoadjuvant Therapy
01/2019 - 01/2013
2Precision Medicine
11/2018 - 11/2018
1Metastasectomy
01/2022
1Combination Drug Therapy (Combination Chemotherapy)
12/2019
1Adjuvant Chemotherapy
12/2017
1Complementary Therapies (Alternative Medicine)
05/2017
1Pain Management
06/2016
1Radiotherapy
06/2016